返回
Zylox-Tonbridge Medical Technology Co., Ltd.（02190.HK）價格
02190.HK 股價走勢圖
ZYLOXTB (02190.HK)
Zylox-Tonbridge Medical Technology Co., Ltd.
HK$25.28
-2.76%
$-0.71
休市： Jan 16, 16:00:00 HKT
暫無資料Earnings FAQ
02190.HK 最近的每股盈餘與預期相比如何？
Zylox-Tonbridge Medical Technology Co., Ltd. 02190.HK 上一季度的收入表現如何？
Zylox-Tonbridge Medical Technology Co., Ltd. 的收入預期是多少？
Zylox-Tonbridge Medical Technology Co., Ltd. 的盈利品質評分是多少？
Zylox-Tonbridge Medical Technology Co., Ltd. 何時發布財報？
Zylox-Tonbridge Medical Technology Co., Ltd. 的預期收益是多少？
Zylox-Tonbridge Medical Technology Co., Ltd. 是否超出收益預期？
關鍵數據
前收市價
$25.62
開盤價
$26
當日範圍
$24.58 - $26.38
52週區間
$10.56 - $28
交易量
590.8K
平均成交量
683.6K
每股盈餘 (TTM)
0.52
股息收益率
--
市值
$8.1B
什麼是 ZYLOXTB？
Zylox-Tonbridge Medical Technology Co., Ltd. engages in the production and sales of neurovascular and peripheral-vascular interventional surgical devices. The company is headquartered in Hangzhou, Zhejiang and currently employs 875 full-time employees. The company went IPO on 2021-07-05. The neurovascular interventional devices primarily include SilverSnake Intracranial Support Catheter, Phoenix Neurovascular Embolization Coil, Tonbridge Kylin Flow Diverter, Thrombite Clot Retriever Device and Beidou SS Neurovascular Guidewire. The peripheral vascular interventional devices primarily include UltraFree Drug Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter, ZYLOX Octoplus Retrievable Inferior Vena Cava Filter, Snare Retrieval Kit for Inferior Vena Cava Filter and ZYLOX Swan Endovenous Radiofrequency Ablation Catheter. The firm primarily operates its businesses in the domestic market and overseas markets, including Germany, France, Italy, and Turkiye.